Ong ACM, Ward CJ, Biddolph S, Migone N, Harris PC
Polycystin expression in PKD-1, infantile PKD-1 and TSC-2/PKD-1
cystic kidney: Evidence against a two-hit disease mechanism in
cyst initiation.
ASN 30th Annual Meeting, San Antonio
J Am Soc Nephrol
(Sep) 8:378A 1997
In the past year, two papers have been published supporting the "two-hit
hypothesis" as the
mechanism of cyst formation in ADPKD1
(see Germino, G.G., Hospital Practice, 3/15/97).
For all
genes on somatic chromosomes, each of the two chromosomes carries a version
(an allele) of the gene.
The hypothesis holds that ADPKD patients inherit one mutated PKD1 allele from
the affected parent
(thus present in all cells), but that the second normal PKD1 allele produces
sufficient Polycystin 1
(Pcys1) protein to support normal cellular function and normal kidney
development. Because of an
intrinsically high mutation rate in the normal PKD1 gene, a random second
mutation in the remaining
normal allele ("somatic" mutation) then abolishes Pcys function in the cell
so affected. Typically
occurring after birth, this leads to a functionally altered renal tubular
cell, which then
proliferates and gives rise to a single cyst. Multiple unique second-hit
mutations lead to multiple
unique cysts. This explains some of the observed variability of the disease
among affected relatives
despite identical mutations in PKD1. This hypothesis predicts that all cells
of a given cyst will
contain similarly mutated allele pairs, one reflecting the inherited germline
mutation (common to
all cells) and the other an acquired mutation unique to a specific cyst.
To test this, Ong et al collected ADPKD1 tissues from 13 cases in which the
germline mutation was
shown to involve loss of the C-terminal end of the Pcys1 protein. Using
monoclonal antibodies which
recognized respectively the N- and the C-terminal ends of the Pcys1 molecule,
the authors reasoned
that positive immunoreactivity for the C terminus indicates expression of the
"normal"
(non-germline, somatic mutant) allele.
The results indicate presence of immunoreactive Pcys1/C
terminus (thus expression of the "normal" allele) in most cysts. A few cysts
exhibited absence of
(immunoreactive) Pcys1 protein, most commonly in very large cysts. Authors
concluded that continued
presence of the "normal" allele in most cyst epithelial cells speaks against
the two-hit
hypothesis.
Comment:
Although attempting to draw major conclusions from abstracted material is
hazardous, the data as
presented raise important questions. First, the antibody method employed
detects immunoreactivity,
not functional activity of Pcys 1 protein. Thus, the persistently expressed
protein from the
"normal" allele could in fact be mutated at a site in the molecule such that
functional activity is
lost while immunoreactivity is retained. Persistence of immunologically
detectable but nonfunctional
protein would not then negate the presence of a second unique mutation in the
previously normal
allele.
It would therefore seem reasonable to withhold judgement until the functional
integrity of
the expressed protein is ascertained. The finding of "absent Pcys" in larger,
thus likely older,
cyst walls may indicate mutational deletion of both alleles; alternatively,
it could indicate
further phenotypic changes in cyst epithelial cells which have undergone
continuous proliferative
cycles. On balance, in my view, the second-hit hypothesis still offers the
best overall explanation
for both clinical and molecular findings but still lacks definitive
documentation.
(Susan P. Bagby, M.D., Oregon Health Sciences University and VA Portland
Medical Center,
Portland, OR)
To go back use the BACK button on your browser.
Otherwise click on the desired link to this article below:
ASN 30th Annual Meeting, San Antonio
Cystic disease :
Hereditary polycystic disease